STL303 clinical trials

A Study in Adults With Geographic Atrophy

This study is testing a new medicine, STL303, for Geographic Atrophy (GA), an eye condition that can cause blurry central vision. We want to see if it's safe and effective in slowing down this vision loss for people aged 60 and over.